These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 27825308)

  • 1. Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study.
    Sadik S; van Rijckevorsel GG; van Rooijen MS; Sonder GJ; Bruisten SM
    BMC Infect Dis; 2016 Nov; 16(1):659. PubMed ID: 27825308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.
    Alberts CJ; Schim van der Loeff MF; Sadik S; Zuure FR; Beune EJAJ; Prins M; Snijder MB; Bruisten SM
    PLoS One; 2018; 13(12):e0208522. PubMed ID: 30557324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
    Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
    Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey.
    van Gageldonk-Lafeber AB; van der Hoek W; Borlée F; Heederik DJ; Mooi SH; Maassen CB; Yzermans CJ; Rockx B; Smit LA; Reimerink JH
    BMC Infect Dis; 2017 Jan; 17(1):21. PubMed ID: 28056844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatitis E virus seropositivity in Dutch blood donors.
    Mooij SH; Hogema BM; Tulen AD; van Pelt W; Franz E; Zaaijer HL; Molier M; Hofhuis A
    BMC Infect Dis; 2018 Apr; 18(1):173. PubMed ID: 29653521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of anti-HEV IgG in 182 Polish patients.
    Bura M; Michalak M; Chojnicki M; Czajka A; Kowala-Piaskowska A; Mozer-Lisewska I
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():320-6. PubMed ID: 25748623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
    Süer K; Güvenir M; Aykaç A
    Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of antibodies to hepatitis A and E viruses in pediatric age groups in Turkey.
    Colak D; Ogunc D; Gunseren F; Velipasaoglu S; Aktekin MR; Gültekin M
    Acta Microbiol Immunol Hung; 2002; 49(1):93-7. PubMed ID: 12073829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis E virus epidemiology in adult population in Edirne province, Turkey].
    Eker A; Tansel O; Kunduracilar H; Tokuç B; Yuluğkural Z; Yüksel P
    Mikrobiyol Bul; 2009 Apr; 43(2):251-8. PubMed ID: 19621610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
    Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
    Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.
    Tholen AT; Schinkel J; Molenkamp R; Ang CW
    PLoS One; 2016; 11(2):e0146906. PubMed ID: 26840767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.
    Vitral CL; da Silva-Nunes M; Pinto MA; de Oliveira JM; Gaspar AM; Pereira RC; Ferreira MU
    BMC Infect Dis; 2014 Aug; 14():458. PubMed ID: 25149658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand.
    Sa-nguanmoo P; Posuwan N; Vichaiwattana P; Wutthiratkowit N; Owatanapanich S; Wasitthankasem R; Thongmee T; Poovorawan K; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    PLoS One; 2015; 10(4):e0126184. PubMed ID: 25927925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis E virus in immigrants: a seroepidemiological survey in the district of Foggia (Apulia-southern Italy).
    Scotto G; Martinelli D; Giammario A; Prato R; Fazio V
    J Med Virol; 2013 Feb; 85(2):261-5. PubMed ID: 23192767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.
    Krumbholz A; Joel S; Dremsek P; Neubert A; Johne R; Dürrwald R; Walther M; Müller TH; Kühnel D; Lange J; Wutzler P; Sauerbrei A; Ulrich RG; Zell R
    Med Microbiol Immunol; 2014 Aug; 203(4):273-82. PubMed ID: 24744181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining prevalence of hepatitis A and silent circulation of hepatitis E virus infection in southeastern Brazil.
    de Almeida E Araújo DC; de Oliveira JM; Haddad SK; da Roza DL; Bottino FO; Faria SBSC; Bellíssimo-Rodrigues F; Passos ADC
    Int J Infect Dis; 2020 Dec; 101():17-23. PubMed ID: 32947056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.
    Bortoliero AL; Bonametti AM; Morimoto HK; Matsuo T; Reiche EM
    Rev Inst Med Trop Sao Paulo; 2006; 48(2):87-92. PubMed ID: 16699630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
    Richardus JH; Vos D; Veldhuijzen IK; Groen J
    J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.
    Cangin C; Focht B; Harris R; Strunk JA
    J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.
    Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC
    J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.